Beclomethason 50 Allgen CFK-vrije Inhalator, aërosol 50 microgram/dosis (RVG 033316 UR)

Patient leaflet (NL)

Indication:
Beclomethason is indicated for the prophylactic management of mild, moderate, or severe asthma in adults or children:

Mild asthma: Patients requiring intermittent symptomatic bronchodilator asthma medication on a regular basis

Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone

Severe asthma: Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms.

Beclomethason 100 Allgen CFK-vrije Inhalator, aërosol 100 microgram/dosis (RVG 033317 UR)

Patient leaflet (NL)

Indication:
Beclomethason is indicated for the prophylactic management of mild, moderate, or severe asthma in adults or children:

Mild asthma: Patients requiring intermittent symptomatic bronchodilator asthma medication on a regular basis

Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone

Severe asthma: Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms.

Beclomethason 250 Allgen CFK-vrije Inhalator, aërosol 250 microgram/dosis (RVG 033318 UR)

Patient leaflet (NL)

Indication:
Beclomethason is indicated for the prophylactic management of mild, moderate, or severe asthma in adults or children:

Mild asthma: Patients requiring intermittent symptomatic bronchodilator asthma medication on a regular basis

Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone

Severe asthma: Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms

Budesonide Allgen 200 CFK-vrije aërosol, aërosoloplossing 200 microgram/dosis (RVG 032251 UR)

Patient leaflet (NL)

Indication:
Treatment of mild, moderate, and severe persistent asthma.

Budesonide Allgen 200 CFK-vrije aërosol + JET, aërosoloplossing 200 microgram/dosis (RVG 032355 UR)

Patient leaflet (NL)

Indication:
Treatment of mild, moderate, and severe persistent asthma.

Formoterol 12 mcg, inhalatiepoeder in harde capsule (RVG 030867 UR)

Patient leaflet (NL)

Indication:
For the long-term symptomatic treatment of persistent, moderate to severe asthma in patients requiring regular bronchodilator therapy in combination with long-term anti- inflammatory therapy (inhaled and/or oral glucocorticoids).

Formoterol is indicated for the relief of broncho-obstructive symptoms in patients with chronic obstructive pulmonary disease (COPD).